Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nu Holdings
NU
5
Liberty Latin America-A
LILA
AU Stock MarketDetailed Quotes
MYX Mayne Pharma Group Ltd
- 7.030
- +0.100+1.44%
20min DelayMarket Closed Apr 24 16:00 AET
571.16MMarket Cap-3.32P/E (Static)
7.040High6.970Low1.02MVolume6.970Open6.930Pre Close7.19MTurnover7.46052wk High1.53%Turnover Ratio81.25MShares3.74052wk Low-1.556EPS TTM470.74MFloat Cap31.320Historical HighLossP/E (Static)66.96MShs Float-10.006Historical Low-2.12EPS LYR1.01%Amplitude--Dividend TTM1.28P/B1Lot Size--Div YieldTTM
About Mayne Pharma Group Ltd Company
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
Company Profile
SymbolMYX
Company NameMayne Pharma Group Ltd
Founded2005
MarketASX
Employees450
Fiscal Year Ends06-30
Address1538 Main North Road Salisbury South
CitySalisbury
CountryAustralia
Zip Code5106
Phone+61 882092666
Websitehttp://www.maynepharma.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067
03 9415 4000
Company Executives
- Name
- Position
- Salary
- Shawn Patrick O’Brien
- Director, Managing Director and Chief Executive Officer
- --
- Frank Charles Condella, M.B.A.
- Chairman of the Board
- --
- David Petrie
- Director
- --
- Professor Bruce Robinson, A.C.,F.R.A.C.P.,M.D.
- Independent Director
- --
- Anne Lockwood
- Independent Director
- --
- Ann Custin, C.P.A.
- Independent Director
- --
- Patrick J. Blake
- Independent Director
- --
- Dr. Kathryn MacFarlane, Pharm.D.
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs